| JUN 15 |
QLT Announces 12-Month Results From Novartis Sponsored MONT BLANC Study Evaluating Standard-Fluence Visudyne® Combination Therapy  |
| |
|
| JUN 02 |
QLT Announces Positive Results From the Evaluation of Visudyne® Combination Therapy |
| |
|
| MAY 21 |
QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court |
|
 |
|
2009 Q1 Earnings Conference Call
QLT broadcasted its Q1 2009 Earnings Conference Call on Tuesday, April 28 at 8:30 am ET. Click here to listen to a replay of the call. |
|
|
|
2009 Proxy Materials and Annual Report
For the 2009 Proxy Statement and Annual Report for the fiscal year ended December 31, 2008, click here. |
|
|
